Trifluoroacetyl Tripeptide-2
A synthetic tripeptide included in some prestige serums and studied, in early research, for its association with the appearance of firmness. It is a smaller, more recently developed entry in the signal-peptide category, formulated at low percentages alongside other peptides rather than used as a standalone active. Public research on it is thinner than on longer-established peptides like copper peptides or Matrixyl, so most of what is documented comes from ingredient-supplier literature rather than independent clinical trials.
Studied for
- ·The appearance of firmness and elasticity
- ·The look of a more supported, resilient-seeming skin surface
- ·Early-stage support for the appearance of smoother-looking texture
How it’s thought to work
Studied for association with the appearance of a more supported skin matrix; the evidence is early and mostly manufacturer-led. As with other short signal peptides, it is thought to work by mimicking a fragment recognized by skin cells, prompting them to behave as though matrix repair is underway, though the specific fragment it is modeled on is not as well documented in public literature as with older peptides.
Questions
- Is Trifluoroacetyl Tripeptide-2 well studied?
- Not as well as older peptides. The evidence base is limited and largely comes from the ingredient supplier rather than independent, peer-reviewed clinical trials, so claims about it are worth treating cautiously.
- How is this peptide usually formulated?
- It typically shows up at a low percentage alongside other signal peptides in multi-peptide serums, rather than as the sole active in a formula, and it is not flagged as air or light sensitive.